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         ABSTRACT 
 
 
The Zinc finger protein 36 like 1 (ZFP36L1) or Butyrate response factor 1 
(BRF1) is involved in the differentiation, proliferation, and angiogenesis of 
various cell types. ZFP36L1 can positively or negatively regulate cellular 
processes such as transcription and signalling, depending on external and 
internal stimulations. The basic mechanism with which this protein 
functions is via its binding to the AU- rich regions of the mRNA causing 
their degradation. However, its exact roles in cellular physiology and mRNA 
targets are poorly understood. We hypothesize that ZFP36L1 regulates 
expression of effectors and receptors linked to immunity and is therefore 
important in controlling cell proliferation and cancer. We investigated roles 
of ZFP36L1 in regulating expression of TNF α and VEGF A as well as of 
the adhesion receptor CD44 involved in lymphocyte activation, 
haematopoiesis and tumour metastasis. In this study we also report data 
on the detection and quantification of ZFP36L1 in several tumour cell lines 
such as THP1, Jurkat, B16, MCF7, and MC38. To study the function of 
ZFP36L1 a CRISPR-Cas9 system was used to generate ZFP36L1 
knockout MC38 cell line. Our results show that ZFP36L1 limits production 
of TNF α and VEGF A. Our preliminary data also show co-localization of 
ZFP36L1 with CD44 upon cellular permeablization, which needs further 
investigation and future studies. In conclusion, we show that ZFP36L1 is 
expressed in various cancer cell lines including Jurkat immune cells and its 
expression regulates various effector molecules and cell growth.    
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CHAPTER 1 
 
Introduction 
 
Zinc finger protein 36 ring like 1 (ZFP36L1) 
 
Zinc finger proteins (ZFPs) are a part of one of the largest families of transcription 
factors in the human genome (Ye et al., 2019), containing conserved zinc finger 
motifs. Recent studies have showed that ZFPs are closely associated with the 
different stages of cancer development such as tumorgenesis, invasion and 
metastasis (Ye et al., 2019). ZFPs function in several biological processes 
including development, differentiation, metabolism and apoptosis. Our ZFP of 
interest is the RNA binding protein ZFP36L1. The zfp36l1 gene encoding for 
protein ZFP36L1 is a member of the immediate early genes (IEGs). 
IEGs are usually activated in response to several types of cellular stimuli. The 
activation and transcription of IEGs takes place within minutes following stimulation 
and does not require the process of de novo protein synthesis (Bahrami and 
Drablos, 2016). Currently, there around 40 known early response genes which 
have been characterised (Baou et al., 2009), ZFP36L1 being one of them. 
ZFP36L1 is a ‘putative’ (post) transcription factor and is an mRNA-binding protein 
(Baou et al., 2009). 
ZFP36L1/BRF 1 is an mRNA binding protein that regulates certain pathways 
related to the growth, development, differentiation and/or maturation of cells. The 
gene encoding the protein is a member of the TIS11 family of IEG’s, consisting of 
4 members; TIS11 (ZFP36), TIS11b (ZFP36L1/BRF 1), and TIS11d 
(ZFP36L2/BRF 2) (Baou et al., 2009). The fourth member ZFP36L3 was found in 
rodents, expressed in mouse placenta, but was not found in human placenta or 
any other human tissues. Our focus will be on ZFP36L1. This gene is well 
conserved across species and has a promoter that contains motifs seen in other 
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early-response genes. This putative nuclear transcription factor most likely 
functions in regulating the response to growth factors (Martinez-Calle et al., 2019). 
 
Structure of ZFP36L1 
 
Zfp36l1 gene was located on chromosome number 14q24.1 and was found to be 
around 6000 base pairs long. The gene consisted of two type Ⅱ restriction 
endonucleases, HINDⅢ and BamHⅢ (Fig 1). These restriction endonucleases are 
responsible for the recognition and cleavage of the AU rich regions. There has 
been no report of a pseudogene gene so far. The conserved tandem zinc finger 
domain (ZFD) (dotted box, Fig 1) directly binds to class Ⅱ AU-rich elements (ARE) 
in the 3'-untranslated region of mRNA.  
 
 
 
 
 
 
 
 
 
In humans, ZFP36L1 protein consisted of 338 amino acids and had an expected 
molecular weight of 36.3 kDa (Stumpo et al., 2010). The structure of ZFP36L1 
consists of five domains each with a distinct role in the activity of the RNA binding. 
Two mRNA decay activation sites are present which are activated upon binding to 
an mRNA, leading to its degradation (Fig 2). Activation sites recruit factors that 
decay the mRNA strand such as de-capping enzymes and exonucleases (Lykke-
Andersen and Wagner, 2005). Structurally, zinc fingers are motifs present in 
proteins that are characterised by one or more zinc ion co-ordinated to stabilize 
the fold.  C3H2 type ZFDs have been known to interact with the 3’ untranslated 
Figure 1: Diagram of genomic structure of human Zfp36l1 gene. The gene consists of two 
exon regions, one at 5’ and second one at 3’ end. A 186 base pair exon at 5’ is followed by 
a large intron spanning 2388 base pairs. This intron is then followed by a 2834bp exon 2. 
A short ZFD (dotted box) exists after the intron region. This region is composed of tandem 
repeats. “START and STOP” regions represent the translation start and stop points. BamH
Ⅲ and HINDⅢ are typeⅡ restriction endonucleases. Adapted from, (Stumpo et al., 2010). 
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region of mRNA. The ZFP36L1 protein consists of two such zinc finger domains 
that are around 20 to 50 amino acids in length. (According to PROSITE ProRule 
annotations) A small but significant domain exists composed of repeated 
homologous serine residues, about 9 amino acids long (Fig 2). At this poly serine 
region phosphorylation takes place, serine residues 92 and 203 respectively 
(Schmidlin et al., 2004). The structure has only been postulated based on 
predictions. Crystallization of the protein would provide a better understanding of 
the protein in future studies. 
 
 
 
 
 
 
 
 
 
 
Mechanism of action 
 
ZFP36L1 protein regulates several cellular processes, including cell apoptosis, by 
binding to AU rich elements in the 3′ untranslated regions of sets of target mRNAs 
to promote their degradation (Schmidlin et al., 2004). Adenylate and uridylate rich 
element (ARE) motifs are elements present in the 3′ untranslated region of mRNA 
transcripts that encode several inflammation and cancer-associated genes 
(Schmidlin et al., 2004).  These zinc finger proteins are known to regulate various 
pathways such as Mitogen activated protein kinases (MAPK), Tumour necrosis 
factor α (TNF α) and vascular endothelial growth factor A (VEGF A). 
The mechanism of ZFP36L1 is a several step process involving the following (Fig 
3):  Protein binding to the ARE region of various mRNAs upon the stimulation of 
differentiation and proliferation (Fig 3A). Phosphorylation of the zinc finger protein 
Figure 2: Domain structure of human ZFP36L1. Region 1 and Region 2: mRNA decay 
activation sites. Two CH2 zinc finger domains (ZFDs) that consists of a co-ordinated 
zinc metal ion. A short region consisting of poly serine amino acid residues. Constructed 
using (Ren et al., 2009). 
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takes place giving it the ability to degrade the mRNA (Fig 3B). Phosphorylation 
takes place by inducing the Serine 92 and 203 on the poly serine region by Protein 
kinase B or MAPK phosphatase. Following phosphorylation, ZFP36L1 recruit 
exosomes, exonucleases and de-capping enzymes (Fig 3C). Thus the 
deadenylation of the poly (A) tail attenuates protein synthesis (Stoecklin et al., 
2002). On the contrary there is evidence of degradation of ARE containing mRNA 
independent of, or in the absence of the poly (A) tail (Lai et al., 2002) (Fig 3D).The 
last step includes hydrolyse and destabilization of mRNA strand rendering it 
inactive. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
C 
D 
Figure 3: Mechanism of ZFP36L1. A) A direct stimulation such as differentiation initiates 
ZFP36L1 to bind. B) Binding to the 3’ untranslated region, promotes phosphorylation of 
the protein. C) Phosphorylation propagates the hydrolysis process with the help of de-
capping enzymes. D) Degradation of mRNA by hydrolysis. 
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Immune receptors in Human Tumour Cells. 
 
14 
 
 
Not only does ZFP36L1 have cytosolic mRNA decay functions, they also present 
nuclear mechanisms (Desroches-Castan et al., 2011). ZFP36L1 have also been 
shown to have post translational modifications for example, by using a proteomic 
method, it was demonstrated that the protein ZFP36L1 binds directly to the low 
density lipoprotein receptor 3'-untranslated region of the mRNA and activated the 
carbon catabolite repression- negative on TATA- less (CCR4-Not) deadenylase 
complex, leading to mRNA instability. Whereas on phosphorylation, the 
deadenylase enzyme complex dissociated from the protein and mRNA was 
stabilized. This shows that ZFP36L1 has important regulatory functions 
(Desroches-Castan et al., 2011). 
 
Regulation of Cell signalling proteins 
 
Negative Regulation 
 
ZFP36L1 has been shown to negatively regulate some effector molecules such as, 
in knockout cell lines derived from mice, the macrophages show high TNF α mRNA 
stability and TNF α production due to the absence of ZFP36L1 (Suk et al., 2019). 
On the other hand, ex vivo studies have shown that, when ZFP36L1 was 
overexpressed, differentiation of adipocytes was suppressed (Tseng et al., 2017). 
Negative regulation can also be seen by pathways of Doxycycline (analogue of 
tetracycline) with granulocyte macrophage-colony stimulating factor (GM-CSF), 
VEGF, cyclooxygenase 2 (COX 2), Cyclin D and B cell lymphoma 2 (Bcl-2) (Fig 4) 
(Suk et al., 2019, Guo et al., 2019). A study clearly showing regulation, says that 
VEGF A production is enhanced in the absence of the respective zinc finger 
protein. When the ZFP36L1 gene was mutated, mice embryo died due to heart 
problems and vascular defects (Bell et al., 2006). On testing the mice it was 
discovered that there was an over production of VEGF A. ZFP36L1 was required 
to keep VEGF A under control and prevent vascular abnormalities; being a 
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negative regulator (Bell et al., 2006). Therefore, functions of ZFP36L1 are linked 
to inflammation, apoptosis, proliferation and angiogenesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Another example of negative regulation suggests that ZFP36L1 negatively 
regulates erythroid differentiation. ZFP36L1 binds to the untranslated region of the 
Stat5b region of the mRNA directly. It was clearly seen that by down regulation of 
the Stat5b pathway, due to ZFP36L1, resulted in decreased levels of erythroid cell 
formation (Vignudelli et al., 2010).  
 
Cell Cycle Regulation 
 
It has been recently proven that ZFP36L1/2 is regulated in a cell cycle-dependent 
manner (Suk et al., 2019, Noguchi et al., 2018). The phosphorylation of this protein 
takes place through its C-terminal region and is an important aspect in its role in 
cell cycle regulation. It has also been shown that ZFP36L1 plays a role in the 
organisation of spindle fibres during mitotic cell division (Kondo et al., 2018). There 
is evidence that overexpression of ZFP36L1/2 led to cell cycle arrest at G1 phase 
and a drastic inhibition in cell growth (Suk et al., 2019). Evaluation of cell cycle 
proteins such as cyclin A, cyclin B, cyclin D and p21 exhibited decreased levels in 
Figure 4: ZFP36L1 is involved in several pathways of the cell. These are some of the 
pathways where the protein has either a negative or positive regulation. ZFP36L1 is 
known to have an effect on inflammatory pathways such as Cycloxygenase 2, TNF α and 
GM-CSF. 
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cells that overexpressed the protein. However, p53 was increased exhibiting the 
role of ZFP36L1/2 in inhibition of cell proliferation in a p53 independent manner 
(Suk et al., 2019). Therefore it can be said that ZFP36L1 is pivotal in the entire cell 
cycle process as it influences various checkpoints, affecting the outcome of the 
cycle (Noguchi et al., 2018, Suk et al., 2019, Kondo et al., 2018).  
 
ZFP36L1 and Cancer 
 
 
RNA-binding proteins (RBPs) perform critical functions in gene expression 
regulation (Oliveira et al., 2017). In all eukaryotes, RBPs play major roles across 
post-transcription processes, such as splicing regulation, mRNA transport, and 
mRNA translation and decay modulation. 
Different pathways and signalling proteins have been investigated to study the 
effects of zinc finger proteins such as, zinc finger protein 367 and its effects on the 
Hippo pathway (Wu et al., 2020), MiR-4282 and the its effect in down regulating 
zinc finger and BTB domain containing 2 (Zhang et al., 2020), Retinoblastoma 
Protein-Interacting Zinc-Finger Gene 1 expression in cervical cancer (Yang et al., 
2019), STAT3 pathway by the Myc-Associated Zinc Finger Protein (Triner et al., 
2018) and PRDI-BF1 and RIZ homology domain zinc finger protein 14 and its role 
in regulation of cancer stemness (Taniguchi and Imai, 2018). The exact functions 
and implications of our protein of interest ZFP36L1 needs further research for 
better understanding.  
The research exploring the relation of cancer with ZFP36L1 is limited but is of 
interest, creating a large scope for finding an effective treatment for cancer. For 
instance, we know that ZFP36L1 influences the VEGF pathway and there is 
research that shows that angiogenesis inhibitors have shown clinical benefits in 
patients with advanced cancer (Planel et al., 2010).  
It can be concluded that by mutating, deleting or repressing the expression of 
zfp36l1 genes, there is direct effect on cell proliferation and division. A study has 
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shown that mice lacking in these genes developed T cell acute lymphoblastic 
leukaemia (Hodson et al., 2010). During the process of thymopoiesis, suppression 
of zfp36l1 led to lymphoblastic leukaemia which was dependent on the 
transcription factor Notch 1 (Hodson et al., 2010). The T cells that are not subjected 
to transformation (ꞵ selection in the thymus) accumulated in large numbers and 
expressed higher levels of Notch 1. However, these cells did not express 
ZFP36L1/2. This can conclude ZFP36L1/2 bound to the AU-rich regions and 
prevented the expression of the mRNA responsible for Notch 1. The results from 
the overall study showed that ZFP36L1/2 is required for the development of T cells 
and prevention of tumours. The deletion or suppression of these proteins led to the 
formation of T-cell lymphoblastic leukaemia (Hodson et al., 2010).  
While ZFP36L1/2 plays an integral role in the prevention of tumours, it can also 
lead to inflammatory responses if not controlled and regulated (Sanduja et al., 
2011). The targeted binding, if not regulated, can lead to inflammatory problems 
for example in the resting state of the cell, the ZFP36L1 destabilises the mRNA of 
pro inflammatory cytokines. The presence of an external stimuli such as 
lipopolysaccharides of microbes signals the ZFP36L1 to temporarily stop its 
mechanism. Therefore there is an increase in the cytokines that help prolong the 
inflammatory response. (Sanduja et al., 2011, Mahmoud et al., 2019). The control 
and regulation of this family of genes takes place at several levels including, cell 
signalling, mRNA turnover number, initiation by phosphorylation, the localization 
and accumulation of cells and interactions with several other proteins, degradation 
of the protoplasm of the cell. All the regulations of the TIS11 family members affect 
the ability of the zinc finger protein to hydrolyse mRNA including functions that are 
independent of decay (Sanduja et al., 2011).  
Lee et al, (2005) demonstrated that ZFP36L1 has a role in the ability of patients to 
respond to chemotherapeutic treatments. The failure of chemotherapeutic drugs is 
one of the major downfalls of cancer treatments, alongside the long-term side 
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effects. Cisplatin is a widely used chemotherapeutic drug, used to specifically treat 
head and neck squamous cell carcinoma (HNSCC). Resistance to cisplatin is 
common amongst patients (Lee et al., 2005), preventing the effective treatment of 
cancer. Cisplatin sensitive and resistant cells derived from HNSCC cell lines were 
used in the study. According to the results, ZFP36L1 showed high expression 
levels in cisplatin-sensitive cells and can be used to improve chemotherapy for 
cancer patients (Lee et al., 2005) 
Now we know that this zinc finger protein plays an intrinsic role in several pathways 
that lead to inflammation and cancer, we can study it further, alongside its 
interactions, to create a therapeutic effect against these issues. 
 
Characteristics of cell surface receptor CD44 
 
 
Cluster of differentiation 44 (CD44) is a cell surface adhesion receptor that is highly 
expressed in many cancers and regulates metastasis via recruitment of CD44 to 
the cell surface. CD44 is a cell-surface glycoprotein involved in cell-cell 
interactions, cell adhesion and migration. Its interaction with appropriate 
extracellular matrix ligands promotes the migration and invasion processes 
involved in metastases. This protein participates in a wide variety of cellular 
functions including lymphocyte activation, recirculation and homing, 
hematopoiesis, and tumor metastasis.  
It has been postulated that the two immune receptors CD74 and CD44 work in 
synergy and play an important role in tumour formation and development (Liu et 
al., 2016, Ssadh et al., 2017)  
CD44 is a typeⅠ trans-membrane glycoprotein (Fig 5) expressed in all majorities 
of cell types. In humans, CD44 plays a major role in adhesion, migration, 
interaction between cells, between cells and extracellular matrix. The specific 
ligands that bind to this receptor include hyaluron and osteopontin (Ssadh et al., 
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2017). Studies show that the expression of CD44 and CD74 is directly proportional 
to the adhesion rates in tumour cells; this study was done using a reconstituted 
membrane matrix ‘Matrigel’ (Ssadh et al., 2017).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Some receptors work together in association with each other like CD74 and 
CD44. This can bring about enhanced tumour development. Is it possible to 
modulate these interactions? Will it cause an overall effect on the integrity of 
the cell? Will it affect other signal pathways? These are some of the questions 
that need to be answered to investigate further possibilities in cancer 
therapeutics. 
 
Cell signalling works in close association with each other and there is a certain 
balance. When this balance is disrupted it leads to cancerous or immunological 
conditions. Recently, it was shown that the collective working of CD44 and 
CD74 leads to the progression of breast cancer (Ssadh et al., 2017). The levels 
Figure 5: Basic structure of CD44. The basic structure includes 3 domains, ligand-
binding homologous extracellular domain, trans-membrane domain and an intracellular 
domain consisting of 20 exons Adapted from (Yasuda et al., 2002). 
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of CD44 and CD74 expressions were seen to be different across different types 
of cells. In some cases, the level of CD44 was higher than CD74. These two 
cell surface receptors come together in the cytoplasm and assist in the 
development and metastasis of cancer (Ssadh et al., 2017). By using advanced 
techniques such as bio imaging and co-immunoprecipitation, the interactions 
were clearly observed and measured to justify its role in tumour development 
and metastasis. Since these receptors play such an important role in the 
development and progression of cancer it can be used as a potential and 
effective biomarker to diagnose cancer (Ssadh et al., 2017). 
 
Relationship between ZFPs and CD44 
 
Few studies have observed the correlation between zinc finger protein and 
CD44 in cancer cells. One such study by Perca B et al, 2015 suggested that a 
specific zinc finger protein; Zinc finger E-box binding homeobox 1 (ZEB1) 
confirmed that CD44 and ZEB1 expression are reciprocally linked in a positive 
feedback loop, that is the isoform of CD44 (CD44s) is expressed which further 
activates more of ZEB1. This suggests that after the initial dependency on 
external growth factors provided by the microenvironment, cancer cells 
become autonomous, a process that is very crucial for tumour progression. Of 
the surviving cells that had undergone Epithelial to mesenchymal transition 
(EMT), CD44s and ZEB1 expression increased sharply while Epithelial Splicing 
Regulatory Protein 1 (ESRP1) were reduced. ESRP1 is thought be a regulator 
of many cancer cells by acting as tumour suppressor (Ishii et al., 2014), hence 
loss or reduction in ESRP1 levels indicate tumour progression and survival. 
They also found out that reduced level of ESRP1 was correlated with increased 
tumour relapse, and the CD44-ZEB1-ESRP1 feedback loop controlling cellular 
phenotypes and prognosis of cancer patients by determining the CD44 isoform 
configuration (Preca et al., 2015). The analysis emphasises that targeting 
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pathways that elevate the expression of ZEB1 and induce a switch that 
contains isoforms of CD44 is an ultimate goal to increase the survival of 
patients with tumours. Promoting the expression of ESRP1 will favour the 
expression of normal CD44, and reduce the isoform subsequently which 
affects the levels of ZEB1 thereby preventing further tumour relapse (Preca et 
al., 2015).  
 
TNF α and VEGF A 
 
 
Tumour necrosis factor alpha is cytokine belonging to the family of TNF/TNFR. 
TNF α plays a significant role in inflammatory signals and host defence 
mechanisms. They are known to maintain homeostasis of the cells (Balkwill, 2006). 
TNF α is produced by macrophages/monocytes in acute inflammatory conditions 
and gives rise to various signalling pathways that leads to apoptosis or necrosis.  
Not only does the cytokine support the immune system during inflammation but 
also takes part in infection resistance and prevention of cancerous conditions 
(Idriss and Naismith, 2000, Zelova and Hosek, 2013). TNF α binds to cell surface 
receptors and is involved in three major groups (MAPK) of signalling pathways. 
These pathways include extracellular-signal-regulated kinases (ERKs), the cJun 
NH2-terminal kinases (JNKs), and p38 MAP kinases (Sabio and Davis, 2014). As 
secondary response is instigated which elevated the expression of TNF α. As 
stated above we have seen that the production of TNF α is regulated by ZFP36L1. 
Therefore we can say that ZFP36L1 also plays a significant role in inflammation 
and immune processes, which needs further investigation. 
 
The formation of new blood vessels (angiogenesis) is a highly important process 
in various processes such as embryonic development, organ development and 
homeostasis, tissue repair, and disease development. A signalling protein most 
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extensively researched is VEGF A. Vessel morphogenesis is regulated via VEGF 
A receptors and is of significance in various roles such as vascular permeability, 
organ regeneration and network patterning (Matsumoto and Ema, 2014). VEGF A 
also aids in angiogenesis in cancerous conditions. They help in tumour progression 
and metastasis, therefore VEGF A inhibitors are vastly studied to prevent the 
further growth of tumours (Frezzetti et al., 2017). As stated above we have seen 
that the production of VEGF A is tightly regulated by ZFP36L1. Therefore we can 
say that ZFP36L1 also plays a significant role in angiogenesis and metastasis, 
which needs further investigation. 
Overall, ZFP36L1 is known to influence several cellular processes that can be 
studied further to evaluate its significance in potential therapies.  
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Aims and Objectives 
 
Aims: ZFP36L1 is an RNA binding protein implicated in cancers therefore goal of 
this project was the analysis of its expression at baseline and upon stimulation in 
various cell lines. Given the nature of this protein in regulating RNA levels, we 
hypothesize that its levels are tightly regulated in cell types and several cellular 
conditions. We also hypothesize that ZFP36L1 regulates expression of effectors 
and receptors linked to immunity and hence important in controlling cell 
proliferation and cancer. 
 
Objectives: Our first step is the detection of the protein in cancer cells and 
quantification of over or under expression of the gene. Our second objective was 
to investigate its roles in regulating expression of TNF α and VEGF A. The 
interaction of this protein with immunological surface receptors such as CD44 was 
also studied. 
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CHAPTER 2 
 
Materials and Methods 
 
Cell Culture 
 
All cell culture experiments were carried out in the Biosafety cabinet. All chemicals 
were brought from Sigma Aldrich unless stated otherwise. Materials that were used 
to carry out all cell culture experiments are as follows. Media: RPMI-1640 with ultra-
glutamine (Lonza, cat. no. BE12-704F/U1); DMEM with 4.5g/L glucose and ultra-
glutamine (Lonza, cat. no. 12-604F/U1); Foetal Bovine Serum (FBS) (Hyclone cat. 
no. SV30160.03); Trypsin; Phosphate Buffer Saline (PBS); Trypan Blue; Phorbol 
12-Myristate 13-Acetate (PMA); Ionomycin; Dymethylsulphoxide (DMSO); 
Micropipettes 10ml and 25ml (Sarstedt) Aspiration tips; 25ml Tissue culture flasks, 
Cell culture dishes (100x20mm and 150x20mm); sterile incubator trays; centrifuge 
tubes 15ml and 50ml; Haemocytometer; cryovials; 2% Chemgene. 
 
Cell Lines 
 
Cell growth is an important aspect in in-vitro studies. It is important to observe the 
characteristics of cell growth to assess the effects of any form of treatment. An 
array of cell lines was cultured and frozen down periodically to prepare stocks. The 
growth media and cell type of each cell line was cultured according to the 
information provided by American Type Culture Collection (ATCC). 
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Cell Line  Cell Type  Disease  Growth 
Type 
Media  Host 
Species 
MCF 7 
 
Epithelial Adenocarcinoma Adehrent DMEM Human 
B16 
 
Epidermal Melanoma Adherent DMEM Mouse 
EL4 
 
T lymphocytes Lymphoma Suspension DMEM Mouse 
Jurkat 
 
T lymphocytes T cell leukemia Suspension RPMI 
1640 
Human 
T47D 
 
Epithelial Ductal carcinoma Adherent RPMI 
1640 
Human 
MC38/WT Epithelial Colon carcinoma Adherent DMEM Mouse 
MC38/KO 
 
Epithelial Colon carcinoma Adherent DMEM Mouse 
THP 1 Monocytes Acute Monocytic 
Leukaemia  
Suspension RPMI 
1640 
Human 
 
Table 1: Summary of cell lines cultured in vitro. 
 
Guide RNA design and cloning.  
 
The sgRNA oligonucleotides (controls: GCGAGGTATTCGGCTCCGCG, 
GCTTTCACGGAGGTTCGACG and ZFP36L1: CACC G 
TCATCGTGGGCGTTCGCACG, TCATCGTGGGCGTTCGCACG), were designed 
using the Broad CRISPR algorithm (Doench et al., 2016). sgRNAs were cloned 
into our sgRNA vector using a BsmBI restriction digest. Vector also expresses Vex 
marker. Cloning was confirmed by sequencing. Frozen aliquots of the knocked 
down cell lines were used for the following experiments. The results of generation 
of knocked down cell lines are discussed in the results section below.  
 
 
 
Zinc Finger Protein 36L1 (ZFP36L1): Gene Expression, Regulation and Interactions with 
Immune receptors in Human Tumour Cells. 
 
26 
 
Cell Revival 
 
Cryovials retrieved from -80⁰C freezers or from liquid nitrogen tanks were allowed 
to defrost rapidly to room temperature in the biosafety cabinet. Once defrosted, the 
entire contents of the vial were poured into the culture plate respectively. 
Suspension Cells - 25ml TC flasks (THP1, Jurkat, EL4) 
Adherent Cells – Culture Dishes (B16, T47D, MCF-7, ZFP36L1MC38WT, 
ZFP36L1MC38KO) 
The media was prepared by the addition of 10% FBS to the 500ml bottle of media 
respectively. This setup was allowed to rest overnight in an incubator with 
conditions 5% CO2, 37⁰C. The following day, cells were checked for adherence 
and the media was changed to remove the freezing mixture. 
 
Cell passaging/splitting 
 
Cells were checked every two days to check for healthy growth. Once the 
plate/flask has reached around 80% confluency, cells were split. Splitting ratio: 1:5- 
1/5th of the total media, i.e. 1/5th of 10ml. (2ml cell suspension with 8ml media) 
Adherent lines: Media was aspirated from the plates. The plates were then washed 
with 5ml PBS to remove any excess media from the plates. The PBS was then 
aspirated. The cells were the trypsinised to detach them from the bottom of the 
plates. (1X) 1ml of trypsin was added to the plates and kept in the warming 
cupboard for 2min. 
Once the cells detach from the bottom of the plate, 9ml media was added (serum 
inhibits trypsin). The cells were mixed thoroughly to prevent any clumping. 2ml of 
cell suspension were transferred to newly labelled plate. 8ml of fresh media was 
added and the cells were allowed to grow for a period of two days. 
Suspension lines: Required amount of cell suspension was pipetted out and 
transferred to a new flask containing fresh media. 
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Cryopreservation 
 
Cryopreservation is important to preserve cell lines for long periods of times (Jang 
et al., 2017). It is also required to prepare stocks for future experiments. Cooling 
to sub-zero temperatures reduces the risk of microbial contamination, cross 
contamination with other cell lines, genetic drift and morphological changes (Pegg, 
2007) The most common freezing mixture used is 90% FBS and 10% DMSO; 
DMSO helps in preventing the formation of crystals within the cells (Jang et al., 
2017). The freezing mixture was cooled before use. The cells were frozen when 
plates reached around 80% and were 1.5-2 × 106 cells/ml. They were frozen at 
passage number 3. 
The cells were trypsinised and centrifuged for 5min at 1200rpm. Supernatant was 
discarded and the pellet was re-suspended with 10ml of freezing mixture. 1ml 
aliquots were dispensed into 10 cryovials. The vials were labelled appropriately 
and transferred to an isopropanol chamber and placed in -80⁰C overnight. They 
were later transferred to liquid nitrogen tanks. 
 
Cell Counting and Viability 
 
It is required to count cells and measure their viability before the start of any in vitro 
cell culture experiments. The haemocytometer was primarily used to count blood 
cells and several adaptations have been used since to improve accuracy and 
increase time efficiency (Cadena-Herrera et al., 2015). Haemocytometer was used 
for cell counting and trypan blue exclusion assay to calculate the viability of the cell 
line. The protocol that we used to count cells and viability before every experiment 
is as follows (Adapted from Abcam website). 
The haemocytometer was cleaned and the coverslip was placed on top of the grid. 
The cell suspension was mixed thoroughly using a pipette for even cell distribution. 
From the suspension 100ul was pipetted into an eppendorf tube. To this equal 
Zinc Finger Protein 36L1 (ZFP36L1): Gene Expression, Regulation and Interactions with 
Immune receptors in Human Tumour Cells. 
 
28 
 
volume (100ul) of trypan blue solution (0.4%) was mixed. Approximately 10ul of 
this mixture was taken and carefully pipetted at the edge of the coverslip (capillary 
action). The grid was focused under the microscope and the cells were counted 
using a tally counter. 
Principle: Live cells and healthy cells have a fully functional cell membrane that 
would not have allowed the entry of any stain such as trypan blue, eosin or 
propidium (Strober, 2015). Dead cells would be stained due to a degraded cell 
membrane. Visually, the cytoplasm of dead cells would be stained blue, whereas 
the live cells would exclude it. 
To calculate the number of live cells in 10ml of cell suspension, live cells were 
counted from 4 large corner squares and recorded. Average was calculated and 
multiplied by 104. Volume of 1 corner square is 10-4 cm3. Value was then multiplied 
with 2 taking into account the dilution factor of trypan blue (1:2). Final volume was 
then multiplied was found to be the number of live cells/ml in cell suspension. 
Viability was counted as, 
No. of live cells/ Total no. of cells ×100 = % viability 
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Western Blot 
 
All chemicals were brought from Sigma Aldrich unless stated otherwise. Resolving 
gel and stacking gel was prepared according to Sambrook et al. (1989) 
 
 
Other reagents that were prepared for the blotting procedure included, running 
buffer (pH 8.3), Loading buffer (2X), Transfer buffer (Made fresh every run), Wash 
buffer (pH 7.6), Blocking buffer. Finer materials are stated in the protocol which 
was adapted from Tahrin Mahmood et al. (2012) 
Principle: Western blotting is a technique mainly used for the separation of 
molecules and proteins based on molecular weight and size. Researchers can 
identify and confirm the presence of the protein of interest from a complex mixture 
of proteins (Ghosh et al., 2014, Mahmood and Yang, 2012) 
The number of cells were counted and recorded as 1.7 × 106 cells/ml; 87% viable. 
Cells were collected by trypsinisation and centrifuged at 1000rpm for 5min. 60ul of 
cell lysis buffer was added to the pellet and incubated for 30min on ice. The lysate 
was then centrifuged at 16,000rpm for 20min at 4⁰C. The supernatant was 
 
12% Resolving 
Gel 
Quantities for 2 
gels (15ml) 
5% Stacking 
Gel 
Quantities for 2 
gels (3ml) 
    
    
Distilled water 4.9ml Distilled water 2.1ml 
    
30% Acrylamide 6.0ml 30% Acrylamide 500ul 
    
1.5M Tris (pH 8.8) 3.8ml 1M Tris (pH 8.8) 380ul 
    
10% SDS 150ul 10% SDS 30ul 
    
10% APS 150ul 10% APS 30ul 
    
TEMED 6ul TEMED 3ul 
    
Table 2: Reagents for the preparation of resolving and stacking gel. 
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collected and stored at -20⁰C. Bradford assay was carried out and the protein 
concentration was found to be 15mg/ml. 
Sample preparation: From the prepared lysate, 10ul was pipetted into a fresh tube 
and was mixed with 15ul of loading buffer (SDS reducing buffer). This was heated 
at 95⁰C for 5min. On loading the samples along with a pre stained protein marker 
(Page ruler plus Pre-stained Protein ladder, cat #26619, Thermo Scientific) the 
gels were run in an electrophoretic tank at respective times: Stacking gel: 50V for 
10-15min. Resolving gel: 120 V for 45-60min until the dye front reaches the bottom 
of the gel. Blotting: Transfer sandwich was prepared and run. 
 
 
All air bubbles were carefully removed. Transfer was done in a tank containing ice. 
Blotting was carried out at 150mA at a high voltage of 500V for 90min. On 
 
ANTIBODY HOST ISO CLASS TYPE CONJUGATE TARGET COMPANY 
   TYPE      
        
BRF1/BRF2 Rabbit IgG Polyclonal Primary Purified ZFP36L1/2 
 
PA5-17364 
Polyclonal       (Invitrogen) 
Antibody        
        
 
HRP Donkey Donkey IgG Polyclonal Secondary HRP BRF 406401 
anti-rabbit     conjugated primary (Bio legend) 
IgG (minimal      antibody  
x-reactivity)        
Antibody        
        
 
Anti-Tubulin Mouse IgG1 Monoclonal Primary Unconjugated Tubulin  
antibody [B-5-     (Protein A- (Control)  
 1-2]     Purified)   
         
 
  
HRP   Goat Goat IgG Polyclonal Secondary HRP Tubulin 405306 
     anti-mouse     conjugated primary (Biolegend) 
IgG (minimal      antibody  
x-reactivity)        
Antibody        
        
 
PD-L1/CD274 Rabbit IgG Polyclonal Primary Unconjugated CD274 17952-1-AP 
Antibody    (Irrelevant   (Proteintech) 
     Antibody)    
         
Table 3: Table summarizing the antibodies used for western blot. 
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completion of the transfer the membrane was washed 3 times with wash buffer. 
Membrane was blocked with 5% blocking buffer for one hour. Membrane was 
washed 3 times, 5min each wash. Primary antibody (BRF1/2 Polyclonal Antibody) 
was added at the dilution 1:1000 and was left overnight at 4⁰C on a shaker. The 
membrane was then washed 3 times. The membrane was then stained with 
secondary antibody (HRP Donkey anti-rabbit antibody) with a dilution of 1:10,000 
for 1 hr. This was followed by a washing step 3 times. The membrane was then 
subjected to primary antibodies (anti- tubulin antibody) as a control and was 
incubated for 1hr at a dilution of 1:1000 and then with secondary antibody (HRP 
Goat anti- mouse antibody) at a dilution of 1:10,000 for 1hr. After the following 
washing steps the membrane was subjected to Enhanced chemiluminescence 
solution (ECL). [ECL solution was prepared by mixing 5ml of solution A and 
solution B as per manufacturer]. The membrane was allowed to stand for 90sec. 
the membrane was then read using the chemiluminescence reader (Fusion). 
Pre-clearing cell lysates: 3.5uL of off-target and irrelevant antibody belonging to 
the same species and isotype as the immunoprecipitation antibody (PD-L1/CD274 
Antibody- Rabbit IgG Polyclonal Primary antibody) to 60ul of lysate. The tubes 
were incubated for 60 min on ice. 6uL of bead slurry was added to the lysate. This 
was incubated for 30 min at 4°C. The tubes were spun in a micro centrifuge at 
12,000 rpm at 4°C for 20 min. Pellet was discarded. 
The entire experiment was repeated twice.  
 
Cell stimulation 
 
The cells were stimulated using PMA/ionomycin at a concentration of 5ng/ml. Cells 
were cultured in 4 dishes and were stimulated with PMA/ionomycin at intervals of 
1hr, 2 hr, 4 hr and 6 hr respectively. The cells were then counted and the viability 
was measured at each time interval. 
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Enzyme Linked Immunosorbant Assay (ELISA) 
 
Two primary ELISA experiments were carried out to study the positive and 
negative regulation expressed by ZFP36L1. As previously discussed, we looked 
into the secretion of two signal proteins TNF α and VEGF A in stimulated 
ZFP36L1WTMC38 and ZFP36L1KOMC38 cell lines. Both the experiments were 
carried out using two ELISA kits as follows, Human TNF α Elisa Ready-Set-Go! 
(eBioscience, ref: 88-7346-88) and Human VEGF A Elisa Kit (Invitrogen, ref: 
BM2772). Both the kits measure proteins present in ‘human’ cells lines whereas, 
the MC38 cell lines are of murine origin. Although according to the description 
received on the kits, it is sensitive to measure proteins from both ‘human and 
murine’ origin. The kits have been specifically tested on human cell lines, but they 
are sensitive to TNF α and VEGF A present in mouse cell lines as well. 
The experiments were carried out using cell suspensions containing 2.6 × 106 
cells/ml. The vials were spun down at 1200rpm for 5min and the supernatant was 
collected. This supernatant that consisted of TNF α and VEGF A was measured.  
 
TNF α measurement: The 96 well plate was coated with 100ul of capture antibody 
diluted in coating buffer and incubated overnight at 4⁰C. The wells were then 
aspirated and washed 4 times using 250ul of wash buffer. The wells were blocked 
with 200ul of ELISA/ELISPOT diluent and incubated for 60 min at room 
temperature. 100ul of standard concentration (500pg/ml) was added to the 
appropriate wells. A two-fold serial dilution was carried out for a total of 7 wells. 
Two wells were used as a blank and to remaining wells 100ul of the samples were 
added. The plate was incubated overnight at 4⁰C. The wells were washed 3 times. 
100ul of detection antibody was added to each well and was kept for incubation at 
room temperature for 60 min. 100ul/well of Avidin-HRP was added and incubated 
for 30 min at room temperature. Plate was washed 7 times. TMB solution was 
Zinc Finger Protein 36L1 (ZFP36L1): Gene Expression, Regulation and Interactions with 
Immune receptors in Human Tumour Cells. 
 
33 
 
added to each well (100ul/well) and left at room temperature for 15 min. After 15 
min 50ul of stop solution was added to all the wells and a colour change was 
observed (blue to yellow). The plates were read at 450nm and analysed using 
Omega software in the Flurostar plate reader. The experiment was repeated twice 
to evaluate significance of results. 
 
 
1 2 3 4 5 6 7 8 
         
 
A Standard Standard ZFP36L1WT ZFP36L1WT ZFP36L1WT ZFP36L1KO ZFP36L1KO ZFP36L1KO 
 (500ng/ml) (500ng/ml) Cells only Cells only Cells only 4 hours 4 hours 4 hours 
         
 
B Standard Standard ZFP36L1WT ZFP36L1WT ZFP36L1WT ZFP36L1KO ZFP36L1KO ZFP36L1KO 
 (425ng/ml) (425ng/ml) 1 hour 1 hour 1 hour 6 hours 6 hours 6 hours 
         
 
C Standard Standard ZFP36L1WT ZFP36L1WT ZFP36L1WT    
 (350ng/ml) (350ng/ml) 2 hour 2 hours 2 hours    
         
 
D Standard Standard ZFP36L1WT ZFP36L1WT ZFP36L1WT    
 (275ng/ml) (275ng/ml) 4 hours 4 hours 4 hours    
         
 
E Standard Standard ZFP36L1WT ZFP36L1WT ZFP36L1WT    
 (200ng/m) (200ng/m) 6 hours 6 hours 6 hours    
         
 
F Standard Standard ZFP36L1KO ZFP36L1KO ZFP36L1KO    
 (125ng/ml) (125ng/ml) Cells only Cells only Cells only    
         
 
G Standard Standard ZFP36L1KO ZFP36L1KO ZFP36L1KO    
 (50ng/ml) (50ng/ml) 1 hour 1 hour 1 hour    
         
 
H Blank Blank ZFP36L1KO ZFP36L1KO ZFP36L1KO    
   2 hours 2 hours 2 hours    
         
 
Table 4: 96 well plate layout to measure the TNF α secretion in MC38 cell line. 
 
VEGF A measurement: The 96 well plate was washed with 400ul/well with wash 
buffer. 100ul of standard concentration (1000pg/ml) was added to the appropriate 
wells containing 100ul of sample diluent. A two-fold serial dilution was carried out 
for a total of 8 wells. Two wells were used as a blank and to remaining wells 50ul 
of the sample diluent was added. To the sample wells 50ul of sample was added. 
The plate was then incubated at room temperature for 120 min. Plate was washed 
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7 times. 100ul of Biotin-Conjugate was added to all the wells and was allowed to 
incubate at room temperature for 60 min. Plate was washed 7 times. Streptavidin-
HRP was added to all the wells (100ul/well) and was incubated at room 
temperature for 60 min. Plate was washed 7 times. TMB solution was added to 
each well (100ul/well) and left at room temperature for 30 min. After 30 min 100ul 
of stop solution was added to all the wells and a colour change was observed (blue 
to yellow). The plates were read at 450nm and analysed using Omega software in 
the Flurostar plate reader. The experiment was repeated twice to evaluate 
significance of results. 
 
 
 
 
 
 
 
 
 
1 2 3 4 5 6 7 8 
         
 
A Standard Standard ZFP36L1WT ZFP36L1WT ZFP36L1WT ZFP36L1KO ZFP36L1KO ZFP36L1KO 
 (1000 pg/ml) (1000 pg/ml) Cells only Cells only Cells only 4 hours 4 hours 4 hours 
         
 
B Standard Standard ZFP36L1WT ZFP36L1WT ZFP36L1WT ZFP36L1KO ZFP36L1KO ZFP36L1KO 
 (500 pg/ml) (500 pg/ml) 1 hour 1 hour 1 hour 6 hours 6 hours 6 hours 
         
 
C Standard Standard ZFP36L1WT ZFP36L1WT ZFP36L1WT    
 (250 pg/ml) (250 pg/ml) 2 hour 2 hour 2 hour    
         
 
D Standard Standard ZFP36L1WT ZFP36L1WT ZFP36L1WT    
 (125 pg/ml) (125 pg/ml) 4 hours 4 hours 4 hours    
         
 
E Standard Standard ZFP36L1WT ZFP36L1WT ZFP36L1WT    
 (62.5 pg/ml) (62.5 pg/ml) 6 hours 6 hours 6 hours    
         
 
F Standard Standard ZFP36L1KO ZFP36L1KO ZFP36L1KO    
 (31.3 pg/ml) (31.3 pg/ml) Cells only Cells only Cells only    
         
 
G Standard Standard ZFP36L1KO ZFP36L1KO ZFP36L1KO    
 (15.6 pg/ml) (15.6 pg/ml) 1 hour 1 hour 1 hour    
         
 
H Blank Blank ZFP36L1KO ZFP36L1KO ZFP36L1KO    
   2 hours 2 hours 2 hours    
         
Table 5: 96 well plate layout to measure the VEGF-A secretion in MC38 cell lines. 
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Bio Imaging 
 
This visualisation technique has been used by several researchers to record 
biological processes in real time. The use of fluorescence technology has come a 
long way in the detection of cell signalling pathways and co-localization. We have 
used this technique to help us observe the presence of interaction and co-
localization between our protein ZFP36L1 and CD44 (cell surface receptor). 
A flask with 80% confluency was chosen. The cells were counted and recorded to 
be 2.3 × 106 cells/ml with 87% viability. A 6 well plate was used to culture cells with 
a single coverslip in each well. The plate was labelled as follows, 
Well 1: ZFP36L1WTMC38 cells only unstimulated. Well 2: ZFP36L1WTMC38 
unstimulated, stained with ZFP36L1 and CD44 antibodies. Well 3: 
ZFP36L1WTMC38 was stimulated with PMA for 4hrs along with ZFP36L1 and CD44 
antibodies. Well 4: ZFP36L1KOMC38 cells only, unstimulated. Well 5: 
ZFP36L1KOMC38 unstimulated, stained with ZFP36L1 and CD44 antibodies. Well 
6: ZFP36L1KOMC38 was stimulated with PMA for 4hrs along with ZFP36L1 and 
CD44 antibodies. 
 
 
 
1 
MC38 WT 
Cells only 
 
 
2 
MC38 WT 
BRF + CD44 
 
3 
MC38 WT 
(PMA) +BRF + CD44 
 
4 
MC38 KO 
Cells only 
 
 
5 
MC38 KO 
BRF + CD44 
 
6 
MC38 KO 
(PMA) + BRF + CD44 
 
Table 6: The 6 well plate layouts. 
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1 ml of cells was loaded in each well. It was allowed to grow for 48hrs till the 
coverslips were completely confluent. Media was changed carefully after 24 hrs. 
Once confluent, the cells were stimulated with PMA (5ng/ml) for 4 hrs. Media was 
discarded. Each well was washed with 1ml PBS twice. 
CD44 Primary Antibody was added to the specific wells on the cover slip at a 
dilution of 1:100. The plate was incubated for 60 min incubation at 4⁰C. Plate was 
washed twice with PBS. CD44 secondary Antibody (green) was then added at 
1:100 dilutions. The plate was then incubated for 60min at 4⁰C. The cells were then 
fixed with 50ul of 4% Paraformaldehyde (PFA) which was incubated for 20min on 
an ice bath. The cells were then made permeable by treatment with 200ul of Triton 
X-100 for 10min. 1ml of blocking buffer was added to each well. (2gm/100ml 
Bovine Serum Albumin (BSA)). Supernatant was removed. The wells washed once 
with PBS to remove any excess triton x. BRF primary antibody was added in 1:100 
dilutions and was allowed to incubate for 1hr at 4ᵒC. Followed by washing steps, 
BRF secondary antibody (red) was added in 1:100 dilutions and was incubated for 
60min in the fridge. The cells were washed with PBS and the coverslips were 
removed with the use of a syringe needle. They were allowed to air dry. To the 
coverslips 10ul of 4′, 6-diamidino-2-phenylindole (DAPI cat. no. H1500, 
Vectasheild Hard set Mounting medium) stain was pipetted and were inverted over 
the slides. They were allowed to air dry for 30 min. The slides were then visualised 
under the confocal microscope. The complete experiment was performed thrice to 
achieve good quality images. 
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ANTIBODY HOST ISO CLASS TYPE CONJUGATE TARGET COMPANY 
  TYPE      
        
 
BRF1/BRF2 Rabbit IgG Polyclonal Primary Unconjugated ZFP36L1 PA5-17364 
Polyclonal       Invitrogen 
Antibody        
        
 
Donkey anti- Donkey IgG Polyclonal Secondary Alexa fluor 555 BRF A-31572 
Rabbit IgG     conjugate primary Life 
(H+L) Highly     (Red) Antibody 
technologie
s 
Cross-        
Adsorbed        
Secondary        
Antibody,        
Alexa Fluor        
555        
        
 
Anti-CD44 Mouse IgG2a Monoclonal Primary Unconjugated CD44 ab6124 
antibody      receptors Abcam 
[F10-44-2]        
        
 
Goat anti- Goat IgG Polyclonal Secondary Alexa fluor 488 CD44 A-11029 
Mouse IgG     conjugate Primary Invitrogen 
(H+L) Highly     (green) Antibody  
Cross-        
Adsorbed        
Secondary        
Antibody,        
Alexa Fluor        
488        
        
 
Table 7: Summary of the antibodies used for the bio imaging protocol. 
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CHAPTER 3 
 
Results 
 
Generation of ZFP36L1KOMC38 stable cells lines 
 
MC38 cell lines expressing Cas9 were transduced with lenti-virus continuing 
control or ZFP36L1 guides vectors. Transduced cells were selected by flow 
cytometry sorting on Vex expression. Vex is fluorescent marker present within the 
vector sequence. Cells were grown in culture and selected again by sorting, until 
purity reached >98%. Gene knockout was confirmed by flow cytometry (FACS) 
and western blot (Fig 6 and Fig 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Crispr-Cas9 knockdown of ZFP36L1 in MC38 cells. Intracellular staining of 
ZFP36L1 in control (A), guide 1 KO (B) and guide 2 (C) transduced MC38 cell using 
primary ZFP36L1 antibody followed by PE-labelled secondary antibody. Prior to staining 
transduced MC38 cell using primary ZFP36L1 antibody followed by PE-labelled 
secondary antibody. Prior to staining transduced cells were selected by flow cytometry 
sorting. 
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Validation of ZFP36L1KOMC38 and other cell lines 
 
 
A second experiment was carried out to detect ZFLP36L1 by western blotting. On 
screening various cancer cells, ZFP36L1 was detected as discreet band around 
36 kDa molecular weight. The bands (Fig 7) at 50 kDa represent the loading control 
β tubulin bands. ZFLP36L1 was visualized at 36 kDa as a single band. Absence of 
the band in the lane containing knocked out MC38 cell line confirmed the knockout 
of gene in ZFP36L1KOMC38 and its precise location on gel in all other cell lines 
tested. Interestingly MCF 7 and ZFP36L1WTMC38 lines showed a slightly higher 
intense band of ZFP36L1 compared to all other lines. Here we concluded that 
ZFP36L1 is widely expressed in various tumour lines and therefore warrants its 
further examination. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Visualization and Detection of ZFP36L1. Nitrocellulose membrane showing ꞵ-
Tubulin and ZFP36L1 bands in several cell lines. Picturisation of western blot showing 
bands at 50 kDa (ꞵ-tubulin control) and bands at 36 kDa (ZFP36L1). The final lane shows 
the absence of ZFP36L1 band, confirming its presence in all other lines. 
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Cell growth and cell test of KO cells 
 
 
All cell lines were grown for an average period of 10 days and cell densities were 
plotted. Cells were counted at the end of each day and the values of viable, live 
cells were recorded. A graph was then plotted to compare growth rates of two cell 
lines (Fig 8). Wild type MC38 lines showed higher growth rate compared to the 
knocked out cell lines. The presence of ZFP36L1 could be attributed to the higher 
growth rate in wild type lines therefore, from the above-mentioned observations, 
we can speculate that ZFP36L1 has a role to play in the growth, proliferation and 
development of MC38 cells.  
 
 
 
 
 
 
 
 
 
 
 
To study roles of ZFP36L1 expression in effector functions of cells we treated cells 
with PMA. Prior to this, we conducted a plot experiment, to assess the appropriate 
treatment conditions for chosen cell lines. The stimulation was carried out over a 
period of 0 to 24 hours. At around 2-5 hours the cells remained stable after which 
they started to deteriorate. The stimulation of cells over the time periods showed 
that the cells were the most viable from 2-5 hours with about 70-50% viability. 
Significant cell death was seen after 4 hours. Therefore, experiments were 
Figure 8: Comparative growth curves of MC38 cell lines. It is clearly seen that MC38WT 
grew at a higher rate than knock out lines rendering them more viable. ”NS” represents 
non-significant value. “*” represents p value < 0.05, significant values (n=2). 
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conducted following PMA treatment at 4 hours when the cells were at maximum 
viability to see the clearest effects of stimulant and prevent confounding factors of 
cell death.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ZFP36L1KOMC38 cells produce higher amounts of inflammatory 
cytokine TNF α compared to wild types. 
 
 
ZFP36L1WTMC38 and ZFP36L1KOMC38 cells were either left untreated or treated 
with PMA from 1h to 6h at a concentration of 500ng/mL (Fig. 9). The cells were 
collected at the time intervals and were subjected to ELISA and the levels of TNF 
α measured as described in method section. As shown previously (Fig 9), the 
optimum stimulation time was found to be 4 hours. We observed that 4hrs TNF α 
secretion was the highest. In addition, we noticed that knockout lines there was a 
steep increase in TNF α levels whereas in wild type lines there was a gradual 
Figure 9: Cells stimulated with PMA. THP 1, MC38WT and MC38KO were stimulated 
over a period of 0 to 24 hours. Cells were the most stable at 4 hours. The significance of 
the result was calculated from the time points 0hr to 6hr.”*” represents the p-value which 
was calculated as .00041. The result is significant at p < 0.05. 
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increase (Fig 11). These results clearly showed that secretion of effector molecules 
was higher in the knocked out cell lines compared to the wild types. The values 
obtained were of significant difference. We concluded that ZFP36L1 was 
responsible for the degradation of mRNA that produces TNF α. We also concluded 
from these results that ZFP36L1 is a negative regulator of TNF α production and 
stability.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Linear standardization of TNF α secretion. A standard graph representing 
concentrations of TNF α ranging from 0pg/ml to 500pg/ml. Substituting the sample 
values in the equation of the standard graph, the concentrations of TNF α is calculated 
for the samples. 
Figure 11: Secretion of TNF α over 6 hours. At 4 hours it was clearly seen that the level 
of TNF α in ZFP36L1WTMC38 was lesser than that of ZFP36L1KOMC38. A t test was carried 
out to obtain the significance of the values. NS- not significant. ‘*’- the p value is 
statistically significant (p<0.05) with (n=2). “**”- the p value is statistically significant 
(p<0.001) with (n=2). 
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ZFP36L1KOMC38 cells produce higher amounts of VEGF A 
compared to wild types. 
 
Our protein of interest, ZFP36L1 regulates the VEGF pathway as mentioned 
previously. This phenomenon was studied by stimulating ZFP36L1WTMC38 and 
ZFP36L1KOMC38 cells with PMA and the VEGF A produced was measured. They 
were treated with PMA (10ul/ml) over a period of 1, 2, 4 and 6hrs. The cells were 
collected at the time intervals and were subjected to ELISA and the levels of VEGF 
A were measured. It was observed that 4hrs was the optimal time for VEGF A 
secretion. The experiment results showed that in knockout lines there was a rapid 
increase in VEGF A levels whereas in wild type lines there was a gradual increase. 
When compared to each other, the levels of VEGF A produced in knock out lines 
were higher than the wild types (Fig 13). We derived at the conclusion that 
ZFP36L1 was responsible for the degradation of mRNA that produces VEGF A. 
This clearly indicates that ZFP36L1 negatively regulates VEGF A production.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Linear standardization of VEGF A secretion. Linear standardization of VEGF A 
secretion. A standard graph representing concentrations of VEGF A ranging from 0pg/ml to 
1000pg/ml. By substituting the sample values in the equation of the standard graph, the 
concentrations of VEGF A was calculated for the samples. 
Zinc Finger Protein 36L1 (ZFP36L1): Gene Expression, Regulation and Interactions with 
Immune receptors in Human Tumour Cells. 
 
44 
 
 
 
 
 
 
 
 
 
 
 
 
 
ZFP36L1 co-localizes with CD44 receptors. 
 
The role of ZFP36L1 in cellular processes such as migration, cell to cell interactions 
and metastasis were evaluated. CD44 was selected as it is highly expressed in 
several cancers. This cell surface receptor is known to regulate metastasis and 
was therefore selected for any possible interactions with ZFP36L1. We would like 
to see if the protein is not only involved in the regulatory aspect of cell signalling 
but also metastasis. This study was carried out using bio imaging where the 
proteins and receptors were stained with specific fluorescence antibodies and were 
visualised using confocal microscopy. If ZFP36L1 presents any co-localization with 
CD44 it can be postulated that the zinc finger has a significant role in migration and 
metastasis (Fig 14). Further studies would be needed to validate the extent of this 
significance of ZFP36L1 in tumour development as the data presented is merely 
preliminary results.    
 
 
Figure 13: Secretion of VEGF A over 6 hours. At 4 hours it was clearly seen that the level 
of VEGF A in ZFP36L1WTMC38 was lesser than that of ZFP36L1KOMC38. A t test was carried 
out to obtain the significance of the values. NS- not significant. ‘**’- The p value is 
statistically significant (p<0.001) with (n=2). 
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ZFP36L1KOMC38 and ZFP36L1WTMC38 cells were stained using two antibodies: 
Anti-ZFP36L1 (red) and Anti-CD44 (green) in the presence and absence of PMA 
stimulation. A blue colour was observed as a result of DAPI stain. The cells were 
permeabilized to allow the red stain to penetrate the cells and stain the intracellular 
protein. The cells were stained intra-cellularly with anti-ZFP36L1 (red) and the 
surface were stained with anti-CD44 (green). An overlay of images show yellow 
visualization if there is any co-localization present. The unstimulated wild type cells 
show limited interaction as the levels of ZFP36L1 is low. There was a slight co-
localization in the unstimulated wild type cells (yellow) (Fig 15 B2). On the other 
hand, the stimulated wild type cells show a slightly higher interaction between the 
two proteins (Fig 15 B3). The slight red seen in the knocked down cell lines can be 
contributed to non-specific staining or background staining (Fig 15 A2 and A3). 
Interestingly the interactions observed are promising and have not been shown 
before. The presence of interaction between ZFP36L1 and CD44 can be quantified 
and studied further. 
 
 
 
Figure 14: Possible interactions between ZFP36L1 and surface receptors. 
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A 
B 
Figure 15: Confocal microscopic images of intracellular CD44 and ZFP36L1 co-localization. 
White circles (A1 and B1) indicate the control showing nuclear staining with DAPI (blue). 
Yellow circles (A2 and A3) indicate stimulated and unstimulated ZFP36L1KOMC38 lines. They 
presented with no yellow visualisation. Red circles (B2 and B3) indicate stimulated and 
unstimulated ZFP36L1WTMC38. Yellow colour represents overlay of the two stains (red and 
green).  
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Chapter 4 
 
Discussion 
 
It has been postulated that the members of ZFP36 family post-transcriptionally 
regulate protein expression by binding to the 3’ untranslated ARE of mRNA and 
activating its degradation in various cancer forms (Bye et al., 2018). The approach 
taken in this study has been to examine a series of cancer derived cell lines 
including adenocarcinomas, melanomas, lymphomas, colon carcinomas and acute 
monolytic leukaemia with the aim of establishing differential expression. In this way 
we narrow down the link between ZFP36L1 and specific forms of cancer. 
ZFP36L1 is an RNA binding protein that controls growth, development, 
differentiation and/or maturation pathways of the cells (Zekavati et al., 2014). Due 
to the nature and function of this protein in regulating RNA levels by de stabilising 
mRNA, it is hypothesised that its levels are regulated in different cells under 
different conditions. An additional aim of this study was to investigate the regulatory 
effects of ZFP36L1 on effector molecules and the immunological receptors CD44. 
Firstly, detection of protein expression at basal level and quantification of it’s the 
expression levels were carried out. Secondly, the cell line ZFP36L1KOMC38 was 
generated using the CRISPR-cas9 system to provide as a negative control for all 
experiments. Thirdly, we examined the role of ZFP36L1 in regulating expression 
of TNF α and VEGF A. Lastly, the interaction of this protein with immunological 
surface receptors such as CD44 was observed. 
ZFP36L1KOMC38 lines were generated using clustered, regularly interspaced short 
palindromic repeats (CRISPR)/cas9 system (Doench et al., 2016). Two guides 
(Guide 1 and Guide 2) were incorporated in two MC38 cell lines expressing cas9, 
an enzyme mediating apoptosis in cells. The cells expressing cas9 were sorted 
using flow cytometry. These cells were re-cultured until the cell lines showed 100% 
purity. The peaks present in the graphs indicate that the cells transduced with guide 
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1 were successfully knocked out, whereas the absence of peaks in graphs 
indicating guide 2 showed that the knockout was unsuccessful. Therefore, this cell 
line was selected as the knockout lines. They were confirmed further using western 
blot. 
The observation of cell growth for the presence of ZFP36L1 in ZFP36L1MC38WT and 
ZFP36L1MC38KO lines has not been shown before, therefore an experiment was 
conducted to compare the two. The cells examined in this study expressed the zinc 
protein ZFP36L1. It is therefore reasonable to assume that the growth of these 
cells may depend on the ZFP36L1 as one of the contributing factors. The THP 1 
cells showed the weakest growth rate of all the cells cultured (data not shown). 
The growth rate of other cell types were observed such as B16, MCF 7 and Jurkat 
(data not shown) and same cell lines were used for Western blotting. We noticed 
the presence of ZFP36L1 in adherent cells at a higher intensity compared to 
suspension cells. Therefore we can say that ZFP36L1 is produced slightly higher 
in epithelial lines than in monocytic cells. Quantitative analysis needs be conducted 
to substantiate the statement. Screening of several cancer cell lines for ZFP36L1 
has not been done before and is a new and significant experiment. 
A steady growing cell line used was the MC38 and further experiments were 
conducted using the respective line. The reason for selection of MC38 lines is its 
implications in testing immunotherapy protocols and in studies on the host immune 
response. MC38 lines are known to be one of the most competent model cell lines 
for the studies of immunological reactions (Minute et al., 2020, Kuang et al., 2020). 
Some of the studies with the implication of MC38 cell lines include, targeting 
immune checkpoints, immune evasion, immune response and used as pre-clinical 
mouse models. Since these lines are regularly used for immunotherapy and cancer 
studies they form a reasonably good in vitro model for the investigation of protein 
expressions (Seyedin et al., 2020).  
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It was observed that wild types showed better cell growth compared to the 
knockouts. They quickly reached confluency and required media changes every 
two days. On the other hand, the knockouts took longer to reach confluency and 
did not consume media as compared to the wild types. It is known that ZFP36L1 
plays a significant regulatory role in cell cycle and proliferation (Suk et al., 2019). 
Therefore we can assume that the knockouts, due to the absence of this protein 
did not grow as steady as the wild type which contained the zinc finger protein. 
There is evidence that ZFP36L1 is involved in growth and cell fate in glioma 
progenitors and glioma cells (Weng et al., 2019). Therefore expression of ZFP36L1 
in this cell line could play a role in tumour genesis, which need further investigation. 
One of the easiest and most reliable methods to detect the presence of a protein 
in a cell or tissue sample is to carry out detection by a Western blot (Mahmood and 
Yang, 2012). Western blot allows to detect the presence of the protein but also to 
quantify the amount of protein present in the samples. ZFP36L1 has not been 
confirmed in MC38 colorectal cancer lines before and therefore could be studied 
further as a possible biomarker. As stated above, the molecular weight of ZFP36L1 
is predicted to be at 36kDa, where the bands are present. The higher intensity 
band above are the control bands tubulin. The bright intensity of the control bands 
resulted in a higher expression of microtubules in all cells. The results prove the 
presence of ZFP36L1 in MC38 wild types and this was confirmed by the lack of a 
band in the knock out lanes. We also noticed that the bands appear fainter in 
suspension cellular lines such as THP 1 and Jurkat, compared to adherent cell 
lines such as MCF 7 and B16 although the amount of protein loaded in all the wells 
were constant.  
Regulatory effects of ZFP36L1 was studied upon stimulation of cells with 
PMA/ionomycin to induce activation pathways within the cell. The over expression 
or under expression of protein was studied by stimulation of cells. The MC38 wild 
types and knockouts were stimulated with PMA/ionomycin as per standard 
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protocol. PMA is known to be a stimulator of differentiation in several lines by 
inducing protein kinase C pathways (Juneja et al., 2017). According to our previous 
studies, the activity of ZFP36L1 is known to be initiated by a stimulus such as 
differentiation and proliferation (Suk et al., 2019, Guo et al., 2019). Therefore the 
stimulator PMA/ionomycin was used to stimulate the cells. The optimum time at 
which the PMA/ionomycin stimulated the cells the most was examined. We needed 
the cells to be the most viable with the highest amount of stimulation. 
PMA takes around 4 hours in adherent lines and show increased proliferation 
(Juneja et al, 2017). The results that we observed were of significant values. The 
cells were stable up to 4 hours following treatment with PMA/ionomycin after which 
the cells began to deteriorate at a faster rate. The cells were collected, counted 
and the viability was calculated. Since we concluded that the cells stimulation is 
optimum at four hours, we harvested the cells before every experiment performed 
at the respective time. Stimulation of cells is an integral part of any protocol when 
investigating protein expression. 
The inflammatory cytokine TNF α is a signalling protein responsible for 
inflammatory responses and the signalling of several other pathways that result in 
apoptosis (Idriss et al, 2000). This protein is tightly regulated as an over production 
of this protein can lead to abnormal cell proliferation and an acute inflammatory 
response (Idriss et al, 2000). Previous studies have shown that ZFP36L1 regulates 
the production of TNF α in a negative manner (Hyatt et al., 2014, Makita et al., 
2020). TNF α expression is controlled by the presence of ZFP36L1 by the 
degradation of its respective mRNA. If the levels of ZFP36L1 are reduced, the 
levels of TNF α exponentially increase which might lead to inflammatory and 
cancerous conditions. Our results showed that ZFP36L1MC38KO expressed higher 
levels of TNF α compared to that of ZFP36L1MC38WT confirming its regulatory effect.   
Previous studies show us that ZFP36L1 regulates the production of VEGF A in a 
negative manner (Ciais et al., 2004, Planel et al., 2010). VEGF A expression is 
Zinc Finger Protein 36L1 (ZFP36L1): Gene Expression, Regulation and Interactions with 
Immune receptors in Human Tumour Cells. 
 
51 
 
controlled by the presence of ZFP36L1, by the degradation of its respective mRNA. 
If the levels of ZFP36L1 are controlled, the levels of VEGF A exponentially increase 
leading to inflammatory and cancerous conditions. This regulatory effect of 
ZFP36L1 was studied experimentally by conducting an ELISA and measuring the 
levels of VEGF A secreted by the cells. As the results depicted, knock out lines 
showed lower levels of VEGF A. This confirmed the regulatory effect. The results 
were promising and the measurements obtained were of significant values. 
By studying the regulatory effects of ZFP36L1 further, we can modulate and modify 
accordingly, to target the proliferation of cells in cancerous conditions. Since the 
signalling proteins are effected by ZFP36L1, we can assume that the protein can 
have a significant effect on the downstream signalling pathways associated with 
the proteins. Which leaves us with the question if it has an effect of one or several 
signalling pathways and if it leads to any major side effects on other parts of the 
tissues.  
Along with the regulatory effects, zinc finger protein was evaluated with respect to 
metastasis and invasion. This experiment to study the interactions of ZFP36L1 with 
a surface immune receptor involved in cell to cell adhesion and metastasis has not 
been done before. We observed a preliminary level of co-localisation that is 
promising to make any further progress in the imaging studies. An overlay of the 
stains used picked up a slight interaction between ZFP36L1 and CD44 allowing us 
to speculate the presence of any form of interaction between the two. The 
confirmation of co-localization can be seen by the overlay of red and green giving 
us a yellow colour.  
Further investigations can be carried out to collect more significant data regarding 
ZFP36L1 and CD74/CD44. The study in this area of research could yield results 
and open an opportunity to discover a therapeutic avenue to treat certain cancers. 
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Conclusion 
 
The main aim of this study was to observe potential role on proliferative and 
effector functions mediated by ZFP36L1. A growth study was carried out to 
compare the growth curves of three cell lines, THP 1, ZFP36L1WTMC38 and 
ZFP36L1KOMC38. Careful examination of cell growth resulted in the confirmation of 
relative effects of ZP36L1 in population doubling time of cells over a period of 7 
days. The presence of ZFP36L1 was confirmed in several cell lines such as Jurkat, 
THP 1, B16, MCF 7 and MC38 by the absence of bands in the ZFP36L1KOMC38 
cell lines. The levels of protein produced by different cell lines were relatively 
observed by the intensity of the bands on the blot. The confirmation of ZP36L1 in 
all cell lines provides information of its potential roles in cellular processes. To 
study its integral role in cellular processes, regulatory effects were examined 
through ELISA experiments. Results indicated the negative regulatory effect of 
ZFP36L1 on two signalling proteins TNF α and VEGF A. TNF α is a well-known 
inflammatory cytokine whereas VEGF A is a known growth factor responsible for 
proliferation of cells. Negative regulatory effects were one of the key findings and 
is promising for further experimentation. The effects of ZFP36L1 with immune 
receptor CD44 was elucidated by performing bio imaging studies. Although the 
data was relatively unclear there was small but significant co-localisation observed 
in stimulated ZFP36L1WTMC38 cells. In conclusion, ZFP36L1 can be investigated 
further to study its effect on downstream signalling pathways and its effects on cell 
proliferation. 
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